Morocco vs Solomon Islands: Prevalence rate of obesity in adults
Morocco
21.6%
in 2024
Solomon Islands
21.8%
in 2024
Morocco rank
110th
Solomon Islands rank
108th
Prevalence rate of obesity in adults over time
- Morocco
- Solomon Islands
How they compare
Solomon Islands currently reports 21.8% against 21.6% in Morocco, a difference of 0.2%.
Across all 45 years both countries report, Solomon Islands has been ahead every year.
Morocco ranks 110th and Solomon Islands ranks 108th of 199 countries.
Solomon Islands has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Morocco | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 6.9% | 11.4% | 4.5% | Solomon Islands |
| 1990s | 9.4% | 13.8% | 4.3% | Solomon Islands |
| 2000s | 13.3% | 16.4% | 3.1% | Solomon Islands |
| 2010s | 17.9% | 18.9% | 1.1% | Solomon Islands |
| 2020s | 20.8% | 21.1% | 0.3% | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of obesity in adults, Morocco or Solomon Islands?
- Solomon Islands, at 21.8% against 21.6% in Morocco as of 2024.
- What is the difference in prevalence rate of obesity in adults between Morocco and Solomon Islands?
- 0.2%, with Solomon Islands ahead.
- How many years of comparable data are there for Morocco and Solomon Islands?
- 45 years are reported by both, from 1980 to 2024.
- How do Morocco and Solomon Islands rank globally for prevalence rate of obesity in adults?
- Morocco ranks 110th and Solomon Islands ranks 108th of 199 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of obesity in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated prevalence of obesity in adults, based on general population surveys and statistical modeling. Obesity is a risk factor for chronic complications, including cardiovascular disease, and premature death.